Evaluation of Treatment Outcomes of Patients with Chronic Phase Chronic Myelogenous Leukemia (CML) to Imatinib: A Single Centre Experience 2010-2015 Period.
- Published in:
- Journal of Natural Science, Biology & Medicine, 2022, v. 13, n. 1, p. 1, doi. 10.4103/jnsbm.JNSBM_13_1_1
- By:
- Publication type:
- Article